119 related articles for article (PubMed ID: 3300559)
1. [Oncogene products as tumor markers].
Shiku H
Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 2):2212-7. PubMed ID: 3300559
[TBL] [Abstract][Full Text] [Related]
2. [Immunoassays of cancer markers--production and analysis of monoclonal antibodies reactive with ras oncogene p21].
Yoshida K; Shiku H
Tanpakushitsu Kakusan Koso; 1987 Sep; (31 Suppl):74-9. PubMed ID: 3321179
[No Abstract] [Full Text] [Related]
3. Preparation of anti-ras Mr 21,000 protein monoclonal antibodies and immunohistochemical analyses on expression of ras genes in human stomach and thyroid cancers.
Yoshida K; Hamatani K; Koide H; Ikeda H; Nakamura N; Akiyama M; Tsuchiyama H; Nakayama E; Shiku H
Cancer Res; 1988 Oct; 48(19):5503-9. PubMed ID: 3046740
[TBL] [Abstract][Full Text] [Related]
4. Enhanced expression of c-Ha-ras p21 in human stomach adenocarcinomas defined by immunoassays using monoclonal antibodies and in situ hybridization.
Ohuchi N; Hand PH; Merlo G; Fujita J; Mariani-Costantini R; Thor A; Nose M; Callahan R; Schlom J
Cancer Res; 1987 Mar; 47(5):1413-20. PubMed ID: 2434216
[TBL] [Abstract][Full Text] [Related]
5. Histologic demonstration of antigens reactive with anti-p21 ras monoclonal antibody (RAP-5) in human stomach cancers.
Noguchi M; Hirohashi S; Shimosato Y; Thor A; Schlom J; Tsunokawa Y; Terada M; Sugimura T
J Natl Cancer Inst; 1986 Aug; 77(2):379-85. PubMed ID: 3525957
[TBL] [Abstract][Full Text] [Related]
6. Characterization of monoclonal antibody R256, specific for activated ras p21 with arginine at 12, and analysis of breast carcinoma of v-Harvey-ras transgenic mouse.
Pullano TG; Sinn E; Carney WP
Oncogene; 1989 Aug; 4(8):1003-8. PubMed ID: 2474786
[TBL] [Abstract][Full Text] [Related]
7. Comparative immunohistochemical reactivity of monoclonal and polyclonal antibodies to H-ras p21 in normal and neoplastic tissues of rodents and humans.
Ward JM; Perantoni AO; Santos E
Oncogene; 1989 Feb; 4(2):203-13. PubMed ID: 2648257
[TBL] [Abstract][Full Text] [Related]
8. Analysis of ras gene expression in stomach cancer by anti-ras p21 monoclonal antibodies.
Yoshida K; Hamatani K; Koide H; Abe Y; Ikeda H; Tsuchiyama H; Nakayama E; Shiku H
Cancer Detect Prev; 1988; 12(1-6):369-76. PubMed ID: 3052835
[TBL] [Abstract][Full Text] [Related]
9. Characterization of monoclonal antibodies specific to the activated ras p21 with aspartic acid at position 13.
La Vecchio JA; Hamer PJ; Ng SC; Trimpe KL; Carney WP
Oncogene; 1990 Aug; 5(8):1173-8. PubMed ID: 2202949
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibody highly sensitive for the detection of ras p21 in immunoblotting analysis.
Kanai T; Hirohashi S; Noguchi M; Shimoyama Y; Shimosato Y; Noguchi S; Nishimura S; Abe O
Jpn J Cancer Res; 1987 Dec; 78(12):1314-8. PubMed ID: 3123435
[TBL] [Abstract][Full Text] [Related]
11. Preparation, characterization and properties of monoclonal antibodies against intact H-ras p21 proteins.
Sorrentino V; Nebreda AR; Alonso T; Santos E
Oncogene; 1989 Feb; 4(2):215-22. PubMed ID: 2467247
[TBL] [Abstract][Full Text] [Related]
12. [Immunohistochemical study of ras p21 expression in human gastric cancers and benign lesions].
Nakajima K
Hokkaido Igaku Zasshi; 1987 Jul; 62(4):573-80. PubMed ID: 3315926
[TBL] [Abstract][Full Text] [Related]
13. [An attempt at using monoclonal antibodies to oncogene products].
Kuzumaki N
Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 2):2205-11. PubMed ID: 3300558
[TBL] [Abstract][Full Text] [Related]
14. Similarity of expression of low molecular weight G proteins smg p21A and ras p21 in normal and malignant human tissues.
Takayama K; Furukawa K; Abe K; Kawase Y; Mizoguchi A; Kikuchi A; Takai Y; Matsui Y; Teranishi Y; Nakayama E
Cancer Res; 1991 Apr; 51(8):2223-8. PubMed ID: 1901241
[TBL] [Abstract][Full Text] [Related]
15. Quantitation of Harvey ras p21 enhanced expression in human breast and colon carcinomas.
Hand PH; Vilasi V; Thor A; Ohuchi N; Schlom J
J Natl Cancer Inst; 1987 Jul; 79(1):59-65. PubMed ID: 3298786
[TBL] [Abstract][Full Text] [Related]
16. [Immunohistological study on ras and myc oncogene products in pancreatic cancer].
Motoshima K; Kohara N; Shiogama T; Fujii M; Nakago S; Tsunoda T; Nagata Y
Nihon Geka Gakkai Zasshi; 1990 Jan; 91(1):123-9. PubMed ID: 2138243
[TBL] [Abstract][Full Text] [Related]
17. Establishment of four mouse hybridoma cell lines producing monoclonal antibodies reactive with ras oncogene product p21.
Kuzumaki N; Oda A; Yamagiwa S; Taniguchi N; Kobayashi H; Oikawa T
J Natl Cancer Inst; 1986 Dec; 77(6):1273-9. PubMed ID: 3540418
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical study of the ras oncogene expression in human breast lesions.
Agnantis NJ; Petraki C; Markoulatos P; Spandidos DA
Anticancer Res; 1986; 6(5):1157-60. PubMed ID: 3541779
[TBL] [Abstract][Full Text] [Related]
19. [Localization of oncoprotein P21ras in the human liver cancer].
Hong JX; Wei MH; Zhang X; Liu YW; Wan DF; Gu JR; Yu XS; Shi DR; Zhang HZ
Zhonghua Zhong Liu Za Zhi; 1987 Mar; 9(2):81-4. PubMed ID: 3308383
[TBL] [Abstract][Full Text] [Related]
20. Antibodies to ras oncogene p21 proteins lack immunohistochemical specificity for neoplastic epithelium in human prostate tissue.
Varma VA; Austin GE; O'Connell AC
Arch Pathol Lab Med; 1989 Jan; 113(1):16-9. PubMed ID: 2462857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
